MHRT: A Potential Drug Target and Biomarker (G104564225)

Target Name: MHRT

NCBI ID: G104564225

MHRT

Other Name(s): myosin heavy chain associated RNA transcript | Myosin heavy chain associated RNA transcript | Myheart

MHRT: A Potential Drug Target and Biomarker

MHRT (Myosin Heavy Chain Associated RNA Transcript) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MHRT is composed of the cytoskeleton protein myosin heavy chain and is expressed in various tissues and cells throughout the body.

The myosin heavy chain is a key component of the cytoskeleton, which is responsible for the structural integrity of muscle and bone cells. MHRT is thought to play a role in the regulation of myosin heavy chain function and has been shown to be involved in a variety of cellular processes, including cell division, differentiation, and stress response.

MHRT has been shown to be involved in the regulation of cell proliferation and has been linked to the growth and development of various tissues and organs. For example, MHRT has been shown to be involved in the regulation of the growth and differentiation of muscle cells and has been shown to play a role in the development of cancer.

In addition to its role in cell proliferation, MHRT has also been shown to be involved in the regulation of cellular stress and has been linked to the development of neurodegenerative diseases. For example, MHRT has been shown to be involved in the regulation of neuroinflammation, which is the inflammation that occurs in the brain in response to injury or disease.

MHRT has also been shown to be involved in the regulation of immune responses and has been linked to the development of autoimmune disorders. For example, MHRT has been shown to be involved in the regulation of the production of antibodies, which are the proteins that are responsible for recognizing and neutralizing foreign substances in the body.

Despite its potential as a drug target and biomarker, MHRT is still a relatively unstudied molecule and much more research is needed to fully understand its role in various diseases. However, the studies that have been done on MHRT suggest that it is a promising molecule for drug development and research.

In conclusion, MHRT is a non-coding RNA molecule that has been shown to be involved in a variety of cellular processes and has the potential to be a drug target and biomarker for various diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments for the conditions associated with MHRT.

Protein Name: Myosin Heavy Chain Associated RNA Transcript

The "MHRT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MHRT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets